Michal Sieczczynski
Overview
Explore the profile of Michal Sieczczynski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
1
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jopek M, Jopek M, Sieczczynski M, Pastuszak K, Lapinska-Szumczyk S, Jassem J, et al.
Blood Adv
. 2024 Dec;
9(5):979-989.
PMID: 39715465
Ovarian cancer (OC) presents a diagnostic challenge, often resulting in poor patient outcomes. Platelet RNA sequencing, which reflects host response to disease, shows promise for earlier OC detection. This study...
2.
Jopek M, Pastuszak K, Sieczczynski M, Cygert S, Zaczek A, Rondina M, et al.
Mol Oncol
. 2024 Jun;
18(11):2743-2754.
PMID: 38887841
Liquid biopsy demonstrates excellent potential in patient management by providing a minimally invasive and cost-effective approach to detecting and monitoring cancer, even at its early stages. Due to the complexity...
3.
Pastuszak K, Sieczczynski M, Dziegielewska M, Wolniak R, Drewnowska A, Korpal M, et al.
Sci Rep
. 2024 May;
14(1):11057.
PMID: 38744942
Circulating tumor cells (CTCs) are tumor cells that separate from the solid tumor and enter the bloodstream, which can cause metastasis. Detection and enumeration of CTCs show promising potential as...
4.
Cygert S, Pastuszak K, Gorski F, Sieczczynski M, Juszczyk P, Rutkowski A, et al.
Cancers (Basel)
. 2023 May;
15(8).
PMID: 37190262
Liquid biopsies offer minimally invasive diagnosis and monitoring of cancer disease. This biosource is often analyzed using sequencing, which generates highly complex data that can be used using machine learning...